GlassScriptPhysician profile
Charles Brodsky
NPI 1346264132
$744.21
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $62.80 · 2021: $93.76 · 2022: $90.59 · 2023: $269 · 2024: $45.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $219.69 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $143.40 | 2019-2024 | Acessa Provu System, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Minerva Surgical, INC | $76.30 | 2021-2024 | |
| Smith+Nephew, INC. | $65.17 | 2019 | |
| Mayne Pharma Commercial LLC | $55.18 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $45.58 | 2023 | Myfembree |
| Astellas Pharma US INC | $28.21 | 2023 | Veozah |
| Millicent US INC | $27.22 | 2020 | |
| Organon LLC | $22.50 | 2022 | |
| Sage Therapeutics, LLC | $16.08 | 2023 | |
| Allergan, INC. | $15.36 | 2019 | |
| Acessa Health INC. | $15.24 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Brodsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.